![]() With 90 percent year-over-year revenue growth, Concerto HealthAI has an expanding list of partners and customers: three of the world’s major biopharmaceutical and oncology organizations have deployed eurekaHealth, and 19 out of the top 25 biopharma are customers of Concerto HealthAI technologies and services. Concerto HealthAI engineers use case-aligned, AI-enriched, validated, and production-ready RWD products and complementary AI-enabled cloud technologies for precision research and patient solutions. These partnerships and relationships are across all major Electronic Medical Record environments, inclusive of next generation sequencing diagnostic information and Patient Reported Outcomes. ![]() Concerto HealthAI has assembled the broadest and most representative clinical network in the industry, through partnerships with the foremost community oncology networks and exclusive licensing with CancerLinQ LLC, a nonprofit subsidiary of the American Society of Clinical Oncology (ASCO). Founded in 2017, Concerto HealthAI is revolutionizing the combination of data and AI to get the right medicines to the right patients faster.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |